Penn Valley, PA, United States of America

Paul F Bray

USPTO Granted Patents = 3 

Average Co-Inventor Count = 1.6

ph-index = 1


Location History:

  • Philadelphia, PA (US) (2017)
  • Penn Valley, PA (US) (2017 - 2020)

Company Filing History:


Years Active: 2017-2020

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Paul F Bray: Innovator in Cardiovascular Therapeutics

Introduction

Paul F Bray is a notable inventor based in Penn Valley, PA (US). He has made significant contributions to the field of cardiovascular medicine, holding a total of 3 patents. His work focuses on innovative therapies that target specific biological pathways involved in cardiovascular diseases.

Latest Patents

Among his latest patents is the "Non-selective protease activated receptor 4 ALA120THR isoform antagonist." This invention is a substance of Formula (I) designed for use as a medicament in treating cardiovascular diseases. The patent outlines various chemical groups and modifications that enhance the efficacy of the treatment. Another significant patent is for "PAR4 inhibitor therapy for patients with PAR4 polymorphism." This patent describes methods for determining the appropriate administration of a PAR4 inhibitor based on genetic markers, specifically targeting individuals with a 'G' allele for a single-nucleotide polymorphism (SNP) at rs773902.

Career Highlights

Paul F Bray is affiliated with Thomas Jefferson University, where he conducts research and develops innovative therapeutic strategies. His work has been instrumental in advancing the understanding of cardiovascular conditions and their treatment.

Collaborations

He collaborates with esteemed colleagues, including Michael Holinstat and Leonard Edelstein, to further enhance the impact of his research and inventions.

Conclusion

Paul F Bray's contributions to cardiovascular therapeutics exemplify the importance of innovation in medicine. His patents reflect a commitment to improving patient outcomes through targeted therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…